These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1944083)

  • 21. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 24. Aortic flow velocity curves in the diagnosis and the followup of symptomatic patent ductus arteriosus in preterm infants during therapeutic interventions.
    Ulmer HE; Knapp G; Wolf D; Wille L; Seyberth HW
    Pediatr Pharmacol (New York); 1983; 3(3-4):167-74. PubMed ID: 6677870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indomethacin or ligation in the treatment of persistent ductus arteriosus: a report of clinical experiences].
    Sterniste W; Fürnkranz H
    Padiatr Padol; 1989; 24(2):153-9. PubMed ID: 2762001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
    Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
    An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibuprofen vs indomethacin for treatment of PDA in preterm infants.
    Gupta P
    Indian Pediatr; 1998 Mar; 35(3):292-3. PubMed ID: 9707894
    [No Abstract]   [Full Text] [Related]  

  • 29. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants.
    Rheinlaender C; Helfenstein D; Walch E; Berns M; Obladen M; Koehne P
    Acta Paediatr; 2009 Jan; 98(1):36-42. PubMed ID: 18764861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical profile and management of symptomatic patent ductus arteriosus in premature infants.
    Shenoi A; Narang A; Bhakoo ON; Bidwai PS
    Indian Pediatr; 1991 Feb; 28(2):125-30. PubMed ID: 2055626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ibuprofen: alternative treatment for patent ductus arteriosus.
    Flores M
    Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indomethacin-induced early patent ductus arteriosus closure cannot be predicted by a decrease in pulse pressure.
    Lubetzky R; Mandel D; Mimouni FB; Diamant S; Birger A; Barak M; Dollberg S
    Am J Perinatol; 2004 Jul; 21(5):257-61. PubMed ID: 15232757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants].
    Monset-Couchard M; Dias-Mançano D; Murat I; Relier JP
    Pediatrie; 1983 Sep; 38(6):365-77. PubMed ID: 6364030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.
    Brooks JM; Travadi JN; Patole SK; Doherty DA; Simmer K
    Arch Dis Child Fetal Neonatal Ed; 2005 May; 90(3):F235-9. PubMed ID: 15846015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of indomethacin in ductus closure: an update evaluation.
    Douidar SM; Richardson J; Snodgrass WR
    Dev Pharmacol Ther; 1988; 11(4):196-212. PubMed ID: 3066603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on management of patent ductus arteriosus in the preterm infant.
    Dani C
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():1. PubMed ID: 21988761
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus.
    Rajadurai VS; Yu VY
    J Paediatr Child Health; 1991 Dec; 27(6):370-5. PubMed ID: 1756081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.